wetzoeker

S3 — BETA-2 AGONISTS Overeenkomst ter bestrijding van doping

BETA-2 AGONISTS

All prohibited substances in this class are prohibited at all times (in- and out-of-competition).

All prohibited substances in this class are Specified Substances

All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited. Including, but not limited to:

Arformoterol

Fenoterol

Formoterol

Higenamine

Indacaterol

Levosalbutamol

Olodaterol

Procaterol

Reproterol

Salbutamol

Salmeterol

Terbutaline

Tretoquinol (trimetoquinol)

Tulobuterol

Vilanterol

EXCEPTIONS

• Inhaled salbutamol: maximum 1.600 micrograms over 24 hours in divided doses not to exceed 600 micrograms over 8 hours starting from any dose

• Inhaled formoterol: maximum delivered dose of 54 micrograms over 24 hours in divided doses not to exceed 36 micrograms over 12 hours starting from any dose

• Inhaled salmeterol: maximum 200 micrograms over 24 hours in divided doses not to exceed 100 micrograms over 8 hours starting from any dose

• Inhaled vilanterol: maximum 25 micrograms over 24 hours

NOTE

The presence in urine of salbutamol in excess of 1.000 ng/mL or formoterol in excess of 40 ng/mL is not consistent with therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of a therapeutic dose (by inhalation) up to the maximum dose indicated above.

Regeling
Overeenkomst ter bestrijding van doping
Soort
Verdrag
Geldend vanaf
01-01-2026
BWB-id
BWBV0004757
Versie
2026-01-01_0

In de hele regeling · Officiële tekst op wetten.overheid.nl